American Asset Management Inc. Geron Corp Transaction History

American Asset Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$0.89 - $1.49 $18,245 - $30,545	-20,500 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$1.15 - $1.59 $575 - $795	500 Added 2.5%	20,500 $27,000
Q2 2019 Jul 31, 2019	SELL	$1.37 - $2.02 $685 - $1,010	-500 Reduced 2.44%	20,000 $28,000
Q1 2019 Apr 15, 2019	BUY	$1.01 - $1.83 $5,050 - $9,150	5,000 Added 32.26%	20,500 $34,000
Q4 2018 Feb 05, 2019	SELL	$0.98 - $1.85 $9,800 - $18,500	-10,000 Reduced 39.22%	15,500 $16,000
Q2 2018 Jul 31, 2018	BUY	$3.29 - $4.82 $8,225 - $12,050	2,500 Added 10.87%	25,500 $87,000
Q1 2018 May 03, 2018	BUY	$1.81 - $5.98 $41,630 - $137,540	23,000 New	23,000 $98,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of American Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on American Asset Management Inc. with notifications on news.